Symposium: Evolutionary Medicine Special Issue

Join eLife authors for an online symposium on December 13 as they showcase their research from the Evolutionary Medicine Special Issue.
Event
  • Views 274

This online symposium, hosted by eLife Senior editor, George Perry of Pennsylvania State University, features four authors presenting key findings from their research in the field of evolutionary medicine, recently published in eLife’s Evolutionary Medicine Special Issue.

From how adaptations to our past lifestyles and pathogens impact risk for current diseases to the emergence and spread of antibiotic-resistant bacteria, evolutionary theory is critical for understanding modern human health.

A short Q&A follows each author presentation.

Free | December 13, 3-4.45pm GMT | 10-11.45am EST

  1. register here

Closed captions provided by otter.ai. Please email events@elifesciences.org if you have any further accessibility requirements.

eLife is committed to providing a safe and welcoming experience for everyone. Please take a few minutes to familiarise yourself with our Code of Conduct – all event attendees are expected to abide by it.

Chair:

George H Perry
Pennsylvania State University, United States

George Perry received his PhD in 2008 from Arizona State University, and did postdoctoral work at the University of Chicago. In 2011, he began a faculty position at Penn State University, where he is now Associate Professor of Anthropology and Biology, Chair of the Bioinformatics and Genomics Graduate Degree Program, and member of the Huck Institutes of the Life Sciences. His research interests focus on human evolution, evolutionary ecology, and evolutionary medicine, and how human behavior and biology have affected non-human evolutionary biology. Research methods and theory from anthropology, evolutionary biology, parasitology, and population, comparative, functional, and paleo (ancient DNA) genomics are integrated in this work. He has received the Faculty Early Career Development (CAREER) Award from the National Science Foundation, among others.

Follow George on Twitter.

Speakers:

Click here to find the times in your time zone.

3.10pm UTC

Stephanie Yan
Johns Hopkins University, United States

Local adaptation and archaic introgression at human structural variant loci
Large genomic insertions, deletions, and inversions are a potent source of functional and fitness-altering variation, but are challenging to resolve with short-read sequencing alone. While recent long-read sequencing technologies have greatly expanded the catalog of structural variants (SVs), their costs have so far precluded their application at population scales. Given these limitations, the role of SVs in human adaptation remains poorly characterized.

Here, we used a graph-based approach to genotype 107,866 long-read-discovered SVs in short-read sequencing data from diverse human populations. We identified 220 SVs exhibiting extreme population-specific allele frequency differentiation — a signature of local adaptation. The top two adaptive signatures traced to variants at the immunoglobulin heavy chain locus, together tagging a 325 Kbp region that swept to high frequency in certain Southeast Asian populations. Further investigation revealed that the adaptive sequence closely matches with that of Neanderthals, providing strong evidence of a Neanderthal-introgressed origin. This extraordinary episode of positive selection, which we infer to have occurred between 1700 and 8400 years ago, corroborates the role of immune-related genes as prominent targets of adaptive archaic introgression.

Read the full Research Article here.

Follow Stephanie on Twitter.

3.30pm UTC

Jerónimo Rodríguez-Beltrán
Ramón y Cajal University Hospital-IRYCIS and CIBERINFEC, Spain

Collateral sensitivity associated with antibiotic resistance plasmids
Collateral sensitivity (CS) is a promising alternative approach to counteract the rising problem of antibiotic resistance (AR). CS occurs when the acquisition of resistance to one antibiotic produces increased susceptibility to a second antibiotic. For CS to be widely applicable in clinical practice, it would need to be effective against the main resistance mechanisms available to bacteria. Recent studies have focused on CS strategies designed against chromosomal resistance mutations. However, one of the main drivers of AR in clinically relevant bacteria is the horizontal gene transfer of AR genes mediated by plasmids. In this talk, we report the first analysis of CS associated with the acquisition of complete AR plasmids, including the clinically important carbapenem-resistance conjugative plasmid pOXA-48. In addition, we explored the conservation of CS in clinical E. coli isolates and its applicability to selectively eliminate plasmid-carrying bacteria. Our results provide new insights that establish the basis for the development of CS-informed treatment strategies to combat plasmid-mediated AR.

Read the full Research Article here.

Follow Jerónimo on Twitter.

3.50pm UTC

Josh D'Aeth
Imperial College London, United Kingdom

Interspecies spread of AMR elements via recombination within pneumococci
Homologous recombination has been known to spread resistance to antimicrobials via the importation of mutations within core Streptococcus pneumonia (the pneumococcus) genes. These resistant sequences often come from closely related commensal species. In this talk though I'll focus on how larger mobile genetic elements (MGEs), particularly Tn1207.1 and Tn916 encoding macrolide and tetracycline resistance respectively, can also be transferred via transformation and recombination into pneumococci populations. I'll show how these elements are often imported from commensal species such as Streptococcus mitis and Streptococcus oralis. This work has important implications both for strategies around mitigating the spread of AMR in important human pathogens and in the wider question of how we define bacterial species that can exchange genes between each other.

Read the full Research Article here.

4.10pm UTC

Juan Manuel Vazquez
University of California, Berkeley, United States

Of Mice and Elephants: Trade-Offs of Tumor Suppressor Duplication and Body Size Evolution in Afrotheria
Peto's Paradox describes the observation that while cancer risk is correlated with body size and lifespan within species, no such correlation holds between species. This indicates that large, long-lived species have evolved enhanced cancer protection mechanisms, and that these mechanisms may be used to treat and even prevent human cancers, and extend the human healthspan. The recent expansion of body size in elephants relative to other members of their resident clade of Afrotheria led us to explore how both body size and lifespan evolved in this group. We found that ancestrally, large body sizes evolved multiple times throughout Afrotheria, and that tumor suppressor duplications were pervasive in Afrotherian genomes, rather than restricted to modern or recent Proboscideans. Proboscideans, however, have duplicates in unique pathways that may underlie some aspects of their remarkable anti-cancer cell biology. These data suggest that duplication of tumor suppressor genes facilitated the evolution of increased body size by compensating for decreasing intrinsic cancer risk.

Read the full Research Article here.

Follow Juan on Twitter.

  1. register here

#

Questions and comments are welcome. Please annotate publicly on the article or contact us at hello [at] elifesciences [dot] org.

For the latest updates and other news from eLife, sign up to receive our bi-monthly newsletter. You can also follow @eLife on Twitter.